Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemours Company (DE:2CU)
FRANKFURT:2CU
Chemours Company (2CU) Stock Price & Analysis
1 Followers
2CU Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€17.64 - €33.75
Previous Close€25.53
Volume0.00
Average Volume (3M)2.71K
Market Cap
$3.61B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta1.33
Next Earnings
Jul 25, 2024EPS Estimate
€0.69Next Dividend Ex-Date
May 14, 2024Dividend Yield3.74%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume2,712
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€30.29Price Target Upside18.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Chemours Company News
PremiumCompany Announcements
Chemours Company Announces Executive Jonathan Lock’s Departure
Bulls Say, Bears Say
Bulls Say
Financial PerformanceChemours Q1'24 EBITDA and EPS beat on margin gains highlights the company's ability to surpass earnings projections, reflecting strong financial health.
Growth PotentialThe company is approaching an inflection point in several of its businesses, suggesting potential for future growth and increased investor confidence.
Leadership And StrategyThe new CEO has a solid plan to drive the company forward, providing confidence in leadership and strategic direction, which is essential for future success.
Bears Say
Corporate GovernanceInternal review by the Audit Committee determined a lack of transparency with the Board of Directors by three former members of senior management, raising concerns over governance practices.
Financial GuidanceThe company's 1Q24 adjusted EBITDA guidance is projected to be significantly below the consensus estimate, signaling potential financial distress.
Management And Operational ConcernsSignificant cash outlays for litigation settlements are anticipated, which may severely impact the company's financial health.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
3.37% Other Institutional Investors
96.63% Public Companies and
Individual Investors
2CU FAQ
What was Chemours Company’s price range in the past 12 months?
Chemours Company lowest stock price was €17.64 and its highest was €33.75 in the past 12 months.
What is Chemours Company’s market cap?
Currently, no data Available
When is Chemours Company’s upcoming earnings report date?
Chemours Company’s upcoming earnings report date is Jul 25, 2024 which is in 84 days.
How were Chemours Company’s earnings last quarter?
Chemours Company released its earnings results on Apr 30, 2024. The company reported €0.299 earnings per share for the quarter, beating the consensus estimate of €0.169 by €0.13.
Is Chemours Company overvalued?
According to Wall Street analysts Chemours Company’s price is currently Undervalued.
Does Chemours Company pay dividends?
Chemours Company pays a Quarterly dividend of €0.23 which represents an annual dividend yield of 3.74%. See more information on Chemours Company dividends here
What is Chemours Company’s EPS estimate?
Chemours Company’s EPS estimate is €0.69.
How many shares outstanding does Chemours Company have?
Currently, no data Available
What happened to Chemours Company’s price movement after its last earnings report?
Chemours Company reported an EPS of €0.299 in its last earnings report, beating expectations of €0.169. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Chemours Company?
Among the largest hedge funds holding Chemours Company’s share is Bridgewater Associates, LP. It holds Chemours Company’s shares valued at 6M.
---
Chemours Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€30.29 (18.64% Upside)
€30.29 (18.64% Upside)
Blogger Sentiment
Bullish
DE:2CU Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.54%
12-Months-Change
Fundamentals
Return on Equity
-25.70%
Trailing 12-Months
Asset Growth
8.00%
Trailing 12-Months
Company Description
Chemours Company
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.
---
2CU Company Deck
---
2CU Earnings Call
Q1 2024
0:00 / 0:00
---
2CU Stock 12 Months Forecast
Average Price Target
€30.29
▲(18.64% Upside)
Technical Analysis
Best Analysts Covering 2CU
1 Year
1 Year Success Rate
11/19 ratings generated profit
1 Year Average Return
+3.09%
reiterated a buy rating 3 months ago
Copying Arun Viswanathan's trades and holding each position for 1 Year would result in 57.89% of your transactions generating a profit, with an average return of +3.09% per trade.
---